Chandigarh, Nov. 9 -- The Haryana Food and Drugs Administration (FDA) has banned the sale, distribution, prescription, or use of cough syrup formulation Planokuf-D in the state following the detection of diethylene glycol (DEG) in the formulation.

The ban has been imposed following a communication from the Central Drugs Standard Control Organization (CDSCO), Guwahati.

Health minister Arti Singh Rao in a statement said that the cough syrup formulation Planokuf D containing cetirizine hydrochloride, phenylephrine hydrochloride, and dextromethorphan hydrobromide, manufactured by M/s Shreya Lifesciences Pvt. Ltd, has been found to contain diethylene glycol. The affected batch, bearing number R25053101, was manufactured in February 2025 and ...